Please assess the completion status of the following clinical trial:

Trial Title: A Pharmacokinetics and Safety Study in Subjects With Renal Impairment

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* BMI between 18.0 and 40.0 kg/m2 inclusive~* Male or female subjects between 18 and 75 years of age~* Stable dosage of medication for 30 days~* for dialysis patients, receiving chronic and stable maintenance hemodialysis for at least 3 months~Exclusion Criteria:~* Functioning transplanted solid organ~* High tyramine diet~* Significant, unstable, or life-threatening condition or organ or system condition or disease, other than kidney disease in renal subjects

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Renal Impairment Nondialyzed (Type: EXPERIMENTAL): None
- Renal Impairment Dialyzed (Type: EXPERIMENTAL): None
- Matched Control (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).